Dr. Joshua Drago is a Medical Oncologist and Breast Cancer specialist at Memorial Sloan Kettering Cancer Center. Dr. Drago’s research efforts include clinical and translational projects across breast cancer subtypes, with a special focus on antibody-drug conjugates and biomarker development in HER2-positive breast cancer. He has been the recipient of the Brian Piccolo Endowed Cancer Research Fellowship Award, Coltman Scholars Award, METAVIVOR Early Career Investigator Award, ASCO/Conquer Cancer Foundation Young Investigator Award, and the K12 Paul Calabresi Career Development Award for Clinical Oncology. Dr. Drago received his medical degree from Harvard Medical School, completed residency training in Internal Medicine at Massachusetts General Hospital, and finished Fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center.
